Table of Contents
A federal judge has dismissed with prejudice a lawsuit from Blue Cross Blue Shield of Georgia that accused medical billing company HaloMD and two physician groups of conspiring to defraud the insurer through the No Surprises Act’s arbitration process. The HaloMD lawsuit dismissed ruling marks the latest in a series of similar outcomes for insurers pursuing comparable claims against the billing company.
What the BCBS Georgia Complaint Alleged
The insurer, part of Elevance Health, alleged in May 2025 that HaloMD, Sound Physicians Emergency Medicine of Georgia and Hospitalist Medicine Physicians of Georgia submitted false attestations of dispute eligibility, flooded the independent dispute resolution system with large volumes of ineligible disputes using AI to overwhelm program safeguards, and submitted inflated payment offers, including some that exceeded the providers’ own billed charges.
The Scale of the Alleged Scheme
The complaint, filed in the U.S. District Court for the Northern District of Georgia, alleged that HaloMD initiated more than 134,000 disputes through the IDR process during the last six months of 2024. In total, BCBS said the three organizations secured nearly $6 million in improper IDR awards and forced it to pay more than $900,000 in related fees.
Why the Judge Ordered the HaloMD Lawsuit Dismissed
In his July 10 decision, Judge Thomas Thrash Jr. wrote that the court lacked jurisdiction over most of the counts and ruled that the racketeering, state-law, ERISA and deceptive trade practice claims were “collateral attacks” on the arbitration decisions, a legal reasoning that has now appeared in multiple similar cases.
A Pattern of Similar Dismissals
In April, a judge in California dismissed another complaint against HaloMD from Elevance’s Anthem Blue Cross, ruling similarly that judicial review of IDR determinations is narrowly constrained. In May, a Texas judge dismissed a lawsuit brought by BCBS Texas against HaloMD on similar grounds, making the Georgia case the third such HaloMD lawsuit dismissed on comparable jurisdictional reasoning.
Other Ongoing Litigation Beyond the HaloMD Lawsuit Dismissed
Additional insurer lawsuits against the medical billing company are ongoing, including one from BCBS plan operator Highmark. Separately, a Florida court dismissed a lawsuit from Aetna against Radiology Partners in April, ruling that the insurer had prior knowledge of the billing practices at the heart of the dispute and did not raise the issue during arbitration.
Context Behind the IDR System’s Volume
The litigation saga has unfolded as the IDR system continues to draw far more volume than regulators anticipated since its launch in 2022, logging more than 5 million disputes against the roughly 17,000 annual filings originally projected. Providers won 85% of disputes in 2024 at median payment determinations of 459% of the qualifying payment amount, up from 327% in 2023, according to a 2025 study published in Health Affairs.
The Judge’s Reasoning Behind the HaloMD Lawsuit Dismissed
“It is highly improbable to infer from these facts that there is a vast conspiracy of providers and IDREs that have conspired to defraud the Plaintiff of millions of dollars in thousands of NSA IDR proceedings over many years,” Judge Thrash wrote in his ruling. “It is highly plausible to infer that the Plaintiff engages in a consistent practice of submitting lowball offers to out-of-network providers in an effort to maximize its profits.”
Elevance’s Response to the Ruling
In a statement, a spokesperson for Elevance told Becker’s the company plans “to appeal with confidence in our position.” “We strongly disagree with the court’s ruling, which we believe misinterprets the No Surprises Act and improperly limits judicial review of the allegations and federal and state claims we asserted in the Amended Complaint that providers and billing companies are misusing the IDR process,” the company said. “Elevance Health will continue to hold billing companies and out-of-network providers accountable for practices that we believe drive up healthcare costs and burden consumers.”
Regulatory Changes Surrounding the HaloMD Lawsuit Dismissed Ruling
In late May, the Trump administration finalized an overhaul of the process that established a centralized disputes portal, created a federal payer registry, and cut per-dispute administrative fees from $115 to $15. HaloMD is one of four organizations, along with TeamHealth, SCP Health and Radiology Partners, that account for the majority of overall dispute filings, according to federal data.
HaloMD’s Response to the Insurer’s Argument
“Insurers have argued that providers’ win rate proves the system is broken,” Patrick Velliky, chief external affairs officer at HaloMD, told Becker’s in a statement. “The Court reached the opposite conclusion: persistent losses by insurers are consistent with low offers. That explanation, along with an insurer arbitration default rate of more than 25%, deserves scrutiny.”
What This HaloMD Lawsuit Dismissed Ruling Means Going Forward
With three separate courts now dismissing similar insurer lawsuits against HaloMD on comparable jurisdictional grounds, the pattern suggests judicial reluctance to second-guess IDR arbitration outcomes through federal litigation. As Elevance pursues an appeal and additional cases, including Highmark’s lawsuit, remain pending, the broader question of how insurers can challenge provider win rates within the No Surprises Act framework remains unresolved, even as regulatory reforms to the IDR process itself continue to take shape.
